|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|
| Revenues: | |||
| Development services and preproduction | |||
| Sale of products | |||
| Total revenues | |||
| Cost of sales and services: | |||
| Development services and preproduction | |||
| Sale of products | |||
| Total cost of sales and services | |||
| Gross profit | |||
| Research and development expenses, net | |||
| Selling and marketing expenses | |||
| General and administrative expenses | |||
| Loss from operations | |||
| Finance income | |||
| Finance expenses | |||
| Derivatives revaluation | |||
| Other income | |||
| Listing expenses | |||
| Company's share in the loss of a company accounted by equity method, net | |||
| Loss before income taxes | |||
| Tax expenses | |||
| Loss for the period | |||
| Other comprehensive income (loss) net of tax: | |||
| Exchange gain (loss) arising on translation of foreign operations | |||
| Total comprehensive loss for the period | |||
| Basic loss per share (in dollars) | |||
| Diluted loss per share (in dollars) | |||
| Basic weighted average common shares outstanding | |||
| Diluted weighted average common shares outstanding |
Loading...